Risk management studies

Requested by health authorities for products placed under surveillance or decided by the pharmaceutical company to accompany the launch of a new product, studies related to the Risk Management have become essential.
CEN Biotech has developed a special expertise in this area resulting from its experience of more than 10 years in the world of pharmacoepidemiology. In particular, we conducted extensive risk management studies in opiate replacement therapy, retinoid in or to accompany the delisting of prescribed drugs as inhibitors of the proton pump which became OTC.
One of our features is to have both the experience of risk management studies in hospitals and in general practice but also in community pharmacies.